# Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

Study · id `cardio:ct-nct01475552` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01475552](<https://clinicaltrials.gov/study/NCT01475552>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01475552

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

## Technical summary

Registry record NCT01475552. Randomized; single masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2011-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT01475552, source copy `cardio:ctgov-nct01475552-2012-12-13`, retrieved 2026-10-26)
- Start date: 2010-09 (registry gives no type) (ClinicalTrials.gov record NCT01475552, source copy `cardio:ctgov-nct01475552-2012-12-13`, retrieved 2026-10-26)
- Primary completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01475552, source copy `cardio:ctgov-nct01475552-2012-12-13`, retrieved 2026-10-26)
- Completion: 2011-10 (actual) (ClinicalTrials.gov record NCT01475552, source copy `cardio:ctgov-nct01475552-2012-12-13`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01475552, source copy `cardio:ctgov-nct01475552-2012-12-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01475552-2012-12-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
- Condition: Diabetes Mellitus
- Intervention (Drug): Abciximab
- Intervention (Drug): control
- Lead sponsor: Seoul National University Bundang Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Seoul National University Bundang Hospital (`cardio:org-seoul-national-university-bundang-hospital`)

## Provenance

Content hash: d9eb963c5418e530ad0c22575401403e1fcc146213b982bd8df0cfa933ca348c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
